Crambescin C1 Exerts a Cytoprotective Effect on HepG2 Cells through Metallothionein Induction
| dc.contributor.affiliation | Universidade de Santiago de Compostela. Departamento de Farmacoloxía | gl |
| dc.contributor.affiliation | Universidade de Santiago de Compostela. Departamento de Fisioloxía | gl |
| dc.contributor.author | Roel Sánchez, María | |
| dc.contributor.author | Rubiolo Gaytán, Juan Andrés | |
| dc.contributor.author | Ternon, Eva | |
| dc.contributor.author | Thomas, Olivier P. | |
| dc.contributor.author | Rodríguez Vieytes, Mercedes | |
| dc.contributor.author | Botana López, Luis Miguel | |
| dc.date.accessioned | 2020-11-09T09:14:12Z | |
| dc.date.available | 2020-11-09T09:14:12Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | The Mediterranean marine sponge Crambe crambe is the source of two families of guanidine alkaloids known as crambescins and crambescidins. Some of the biological effects of crambescidins have been previously reported while crambescins have undergone little study. Taking this into account, we performed comparative transcriptome analysis to examine the effect of crambescin-C1 (CC1) on human tumor hepatocarcinoma cells HepG2 followed by validation experiments to confirm its predicted biological activities. We report herein that, while crambescin-A1 has a minor effect on these cells, CC1 protects them against oxidative injury by means of metallothionein induction even at low concentrations. Additionally, at high doses, CC1 arrests the HepG2 cell cycle in G0/G1 and thus inhibits tumor cell proliferation. The findings presented here provide the first detailed approach regarding the different effects of crambescins on tumor cells and provide a basis for future studies on other possible cellular mechanisms related to these bioactivities | gl |
| dc.description.peerreviewed | SI | gl |
| dc.description.sponsorship | FEDER cofunded-grants. CDTI and Technological Funds, supported by Ministerio de Economía y Competitividad, AGL2012-40185-CO2-01 and Consellería de Cultura, Educación e Ordenación Universitaria, GRC2013-016, and by Axencia Galega de Innovación, Spain, ITC-20133020 SINTOX, IN852A 2013/16-3 MYTIGAL. CDTIunderISIP Programme, Spain, IDI-20130304 APTAFOOD. European Union’s 7th Framework Programme managed by Research Executive Agency (FP7/2007-2013) under grant agreement Nos. 265409 µAQUA, 315285 CIGUATOOLS and 312184 PHARMASEA | gl |
| dc.identifier.citation | Roel, M.; Rubiolo, J.A.; Ternon, E.; Thomas, O.P.; Vieytes, M.R.; Botana, L.M. Crambescin C1 Exerts a Cytoprotective Effect on HepG2 Cells through Metallothionein Induction. Mar. Drugs 2015, 13, 4633-4653 | gl |
| dc.identifier.doi | 10.3390/md13084633 | |
| dc.identifier.essn | 1660-3397 | |
| dc.identifier.uri | http://hdl.handle.net/10347/23611 | |
| dc.language.iso | eng | gl |
| dc.publisher | MDPI | gl |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/FP7/312184 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/FP7/315285 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/FP7/265409 | |
| dc.relation.publisherversion | https://doi.org/10.3390/md13084633 | gl |
| dc.rights | © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/) | gl |
| dc.rights | Atribución 4.0 Internacional | |
| dc.rights.accessRights | open access | gl |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Crambescin-C1 | gl |
| dc.subject | Crambescin-A1 | gl |
| dc.subject | Metallothionein | gl |
| dc.subject | Crambe crambe | gl |
| dc.subject | Sponge-derived compounds | gl |
| dc.subject | Transcriptome profiling | gl |
| dc.subject | Antioxidant effect | gl |
| dc.subject | Cell cycle inhibition | gl |
| dc.title | Crambescin C1 Exerts a Cytoprotective Effect on HepG2 Cells through Metallothionein Induction | gl |
| dc.type | journal article | gl |
| dc.type.hasVersion | VoR | gl |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 6574bec8-97de-4fab-b2ba-d35b85751f34 | |
| relation.isAuthorOfPublication | 91f88e2e-ed1a-43f4-a16c-8d8d5c998e40 | |
| relation.isAuthorOfPublication | 9a18ed42-77b6-4760-8303-ff4070a87ca6 | |
| relation.isAuthorOfPublication.latestForDiscovery | 6574bec8-97de-4fab-b2ba-d35b85751f34 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2015_marinedrugs_roel_crambescin.pdf
- Size:
- 4.84 MB
- Format:
- Adobe Portable Document Format
- Description: